
Organic Process Research and Development p. 336 - 345 (2017)
Update date:2022-07-31
Topics:
Goundry, William R. F.
Boardman, Kay
Cunningham, Oliver
Evans, Matthew
Jones, Martin F.
Millard, Kirsty
Rozada-Sanchez, Raquel
Sawyer, Yvonne
Siedlecki, Paul
Whitlock, Brian
Recently, the aminoquinazoline motif has been highly prevalent in anticancer pharmaceutical compounds. Synthetic methods are required to make this structure on a multikilo scale and in high purity. The initial route to aminoquinazoline AZD8931 suffered from the formation of late-stage impurities. To avoid these impurities, a new high-yielding Dimroth rearrangement approach to the aminoquinazoline core of AZD8931 was developed. Assessment of route options on a gram scale demonstrated that the Dimroth rearrangement is a viable approach. The processes were then evolved for large-scale production with learning from a kilo campaign and two plant-scale manufactures. Identification of key process impurities offers an insight into the mechanisms of the Dimroth rearrangement as well as the hydrogenation of a key intermediate. The final processes were operated on a 30 kg scale delivering the target AZD8931 in 41% overall yield.
Hangzhou Donglou Bio-nutrient Co., Ltd.
Contact:+86-571-82225795,13967112289
Address:Louta Town, Xiaoshan,Hangzhou,Zhejiang
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
website:http://www.trustwe.com
Contact:+86-21-61551413
Address:601, No. 1, 2277 Nong, Zu Chongzhi Road, Zhangjiang Hightech. Park, Pudong
Anhui Gusheng Import&Export CO.,LTD
Contact:86-551-63662296
Address:Jinzhai Road NO.162 ,hefei, china
Beijing Century Richap Chemistry Co.,Ltd
Contact:+86- 010-64455497
Address:Guannan County, Lianyungang City, Jiangsu Province, China
Contact:+86-0311-84455288-844
Address:Mayu Industrial Park, Jinzhou, Hebei, China.
Doi:10.1021/ja00191a036
(1989)Doi:10.1016/j.carres.2009.08.028
(2009)Doi:10.1016/j.jfluchem.2005.02.020
(2005)Doi:10.1002/anie.200903558
(2009)Doi:10.1021/acsmedchemlett.7b00296
(2017)Doi:10.1246/cl.1988.1639
(1988)